Gilead Sciences GILD
NASDAQ GILD
$166.89 -0.68 (-0.41%)
At close: Nov 6, 2026 · 4:00 PM EST

Gilead Sciences (GILD) Asset Writedowns and Impairment (2016 - 2026)

Updated

Analysis

Gilead Sciences (GILD) Asset Writedowns and Impairment (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.75 Bn
Dec 31, 2025 400.00 Mn
Jun 30, 2025 190.00 Mn
Sep 30, 2024 1.80 Bn
Mar 31, 2024 2.43 Bn
Dec 31, 2023 50.00 Mn
Mar 31, 2022 2.70 Bn
Dec 31, 2016 201.00 Mn
Sep 30, 2016 117.00 Mn
Mar 31, 2016 114.00 Mn
API Access

Gilead Sciences Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=GILD&period=max&api_key=YOUR_API_KEY